Menu
ThermoBreast was a Horizon Europe funded project involving a multidisciplinary consortium of 15 international partners from 11 countries. It aimed to contribute to the European Union’s Mission on Cancer and Beating Cancer Plan, striving to drastically improve the prevention, diagnosis and monitoring of breast cancer, as well as reduce the burden on female patients, their families, healthcare professionals, and all others affected by breast cancer directly or indirectly.
One of the main aims of the European Mission on Cancer is to enhance cancer prevention for EU citizens. This involves improving the effectiveness of existing screening programs and conducting research to develop new screening tools that can be easily integrated into new programs at a national level. The European Commission has provided support and encouragement for this mission, resulting in collaborative efforts amongst seven EU-funded projects, united under the “Prevention and early detection (Screening)” cluster, which ThermoBreast was proud to be part of.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them (grant agreement no. 101096329).
Swiss participants in this project were supported by the Swiss State Secretariat for Education, Research and Innovation (contract no. 22.00518).